Acanthopanax Xuesaitong the treatment of cerebral insufficiency combined clinical observation.docVIP

 PAGE \* MERGEFORMAT 7 Acanthopanax Xuesaitong the treatment of cerebral insufficiency combined clinical observation Study: Fat Tse first, Zhang and Gong, Wang Hongze, Zhou Xuekai [Abstract] Objective To observe the joint Acanthopanax Xuesaitong clinical treatment of cerebral insufficiency. Methods 40 cases of cerebral insufficiency were divided into treatment and control groups. The treatment group 20 cases Xuesaitong injection 300mg, Acanthopanax intravenous injection 20ml, 1 / d, a total of 14d, the control group 20 cases Xuesaitong injection 300mg, citicoline intravenous injection 0.5g, 1 / d, a total of 14d. The results of two comparison group of drugs effective in the treatment group than the control group (P lt;0.01. Conclusion Xuesaitong United Acanthopanax is effective and the treatment of cerebral insufficiency. [Keywords:] cerebral insufficiency, Xuesaitong, Acanthopanax Cerebral vascular insufficiency is common disease occurring disease is the result of brain blood circulation, it can lead to blood supply area of #8203;#8203;focal neurological dysfunction is characterized by a group of diseases, because of its ease the slow, high recurrence rate, so the treatment has difficulty, the author combined with Xuesaitong Acanthopanax treatment of cerebral vascular insufficiency with good results. are reported below. 1 Clinical data 1.1 General information on 20 patients in this group. M 12, 8 females, age: 25 ~ 66 years, mean 40.5 + -6.5 years old. All the cases are dizziness, headache as the initial symptom, in line with WHO of the transient 1989 cerebrovascular insufficiency developed diagnostic criteria [1]. and the exclusion of heart, liver, endocrine and metabolic diseases. line head CT to exclude intracranial hemorrhage and cerebral infarction, patients were divided into treatment and control groups. the treatment group 20 males and 13 cases 7 females, age: 45 to 65 years, with an average age of 58.4 + -5.5 .11 patients with visual